Blitz Triple G
from €99.90
Blitz Triple G as a lyophilisate in a sealed vial, available in 10 mg, 20 mg, 30 mg, 60 mg. A synthetic multi-target research peptide of the GLP-1/GIP/glucagon class. For in-vitro laboratory research only (RUO).
B3-023502
July 2026
PDF ↓Scientific data sheet
- CAS number
- 2381089-83-2
- Molecular formula
- C₂₂₁H₃₄₂N₄₆O₆₈
- Purity
- ≥99% (HPLC-verified)
- Sequence
- 39 amino acid peptide
- Class
- Triple agonist (GLP-1 / GIP / Glucagon)
- Appearance
- White lyophilised cake
A synthetic multi-target research peptide of the GLP-1/GIP/glucagon class.
Triple agonist at the GLP-1, GIP and glucagon receptors; studied in receptor-binding and cAMP-response models.
Supplied as a lyophilised powder in a sealed glass vial (10 mg, 20 mg, 30 mg, 60 mg). The purity and identity of each batch are determined by HPLC and LC-MS; the batch-specific Certificate of Analysis is available on this page.
Store cool, dry and protected from light; for longer storage at -20 °C.
Research Use Only. This product is intended exclusively for scientific in-vitro laboratory research. Not for use in humans or animals. Not a medicine, food or cosmetic. No therapeutic, diagnostic or health-related effects are claimed.
- Form
- Lyophilised powder
- Container
- Glass vial, sealed
- Solvent
- Not included
- Testing
- HPLC, LC-MS, identity testing
- Origin
- Synthetic
- Purity
- ≥99% (HPLC-verified)
- Amount
- 10 mg | 20 mg | 30 mg | 60 mg
- Form
- lyophilised powder
- CAS number
- 2381089-83-2
- Molecular formula
- C221H342N46O68
Store cool, dry and protected from light. Lyophilised powder recommended at 2–8 °C; −20 °C for longer storage.
For research use only (RUO). This product is intended exclusively for scientific laboratory research. Not for human consumption, not for therapeutic use and not for veterinary purposes. No dosage recommendations, no health claims.




